Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

    This grant funds milestone-driven preclinical research to develop and advance new therapies for visual system diseases, supporting projects from early-stage lab findings through FDA IND/IDE submission readiness.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)

    NEI grant supports planning for large clinical vision research projects including trials and studies on eye conditions, requiring detailed study protocols and procedures.

    HHS-NIH11Due Nov 16, 2026· 21d$150,000

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.

    HHS-NIH11Due Dec 1, 2030$6,000,000

    Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

    NHLBI Catalyze funds early-stage medical device prototypes, disease target ID, & assay development for heart, lung, blood, & sleep disorders, aiming to prep projects for further testing.

    HHS-NIH11Due Nov 23, 2026